Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis

Jennifer L. Nalepka, Michael J. Lee, Matthew J. Kraay, Randall E. Marcus, Victor M. Goldberg, Xin Chen, Edward M. Greenfield

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Aseptic loosening of orthopaedic implants occurs in the absence of clinical signs of infection. Nevertheless, bacterial endotoxins derived from subclinical infections, systemic sources, or the implant manufacturing process may contribute to aseptic loosening. Also, the rate of implant infection is greater in patients with inflammatory arthritis than in patients with osteoarthritis. We hypothesized that lipopolysaccharide, the classic endotoxin derived from gram-negative bacteria, is more prevalent in periprosthetic tissue surrounding aseptically loose implants in patients with inflammatory arthritis than in patients with osteoarthritis. To test this, we used a modified Limulus amebocyte assay not affected by β-glucan-like molecules in mammalian tissues. Lipopolysaccharide rarely was detected in periprosthetic tissue from patients with osteoarthritis and aseptic loosening (one of six patients). In contrast, lipopolysaccharide was detected despite the absence of any clinical signs of infection in peri-prosthetic tissue from all four patients with inflammatory arthritis (rheumatoid arthritis, juvenile rheumatoid arthritis, and systemic lupus erythematosus). Lipopolysaccharide also was detected in two patients with gram-negative infections, who were included as positive control subjects. Endotoxins derived from low-grade or systemic bacteremia may be important contributors to aseptic loosening particularly in patients with autoimmune conditions such as inflammatory arthritis.

Original languageEnglish (US)
Pages (from-to)229-235
Number of pages7
JournalClinical orthopaedics and related research
Issue number451
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Arthritis
Lipopolysaccharides
Endotoxins
Osteoarthritis
Infection
Horseshoe Crabs
Asymptomatic Infections
Glucans
Juvenile Arthritis
Bacteremia
Gram-Negative Bacteria
Systemic Lupus Erythematosus
Orthopedics
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis. / Nalepka, Jennifer L.; Lee, Michael J.; Kraay, Matthew J.; Marcus, Randall E.; Goldberg, Victor M.; Chen, Xin; Greenfield, Edward M.

In: Clinical orthopaedics and related research, No. 451, 10.2006, p. 229-235.

Research output: Contribution to journalArticle

Nalepka, Jennifer L. ; Lee, Michael J. ; Kraay, Matthew J. ; Marcus, Randall E. ; Goldberg, Victor M. ; Chen, Xin ; Greenfield, Edward M. / Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis. In: Clinical orthopaedics and related research. 2006 ; No. 451. pp. 229-235.
@article{5b4bb15fc5364434a1f843864dc26e98,
title = "Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis",
abstract = "Aseptic loosening of orthopaedic implants occurs in the absence of clinical signs of infection. Nevertheless, bacterial endotoxins derived from subclinical infections, systemic sources, or the implant manufacturing process may contribute to aseptic loosening. Also, the rate of implant infection is greater in patients with inflammatory arthritis than in patients with osteoarthritis. We hypothesized that lipopolysaccharide, the classic endotoxin derived from gram-negative bacteria, is more prevalent in periprosthetic tissue surrounding aseptically loose implants in patients with inflammatory arthritis than in patients with osteoarthritis. To test this, we used a modified Limulus amebocyte assay not affected by β-glucan-like molecules in mammalian tissues. Lipopolysaccharide rarely was detected in periprosthetic tissue from patients with osteoarthritis and aseptic loosening (one of six patients). In contrast, lipopolysaccharide was detected despite the absence of any clinical signs of infection in peri-prosthetic tissue from all four patients with inflammatory arthritis (rheumatoid arthritis, juvenile rheumatoid arthritis, and systemic lupus erythematosus). Lipopolysaccharide also was detected in two patients with gram-negative infections, who were included as positive control subjects. Endotoxins derived from low-grade or systemic bacteremia may be important contributors to aseptic loosening particularly in patients with autoimmune conditions such as inflammatory arthritis.",
author = "Nalepka, {Jennifer L.} and Lee, {Michael J.} and Kraay, {Matthew J.} and Marcus, {Randall E.} and Goldberg, {Victor M.} and Xin Chen and Greenfield, {Edward M.}",
year = "2006",
month = "10",
doi = "10.1097/01.blo.0000224050.94248.38",
language = "English (US)",
pages = "229--235",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "451",

}

TY - JOUR

T1 - Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis

AU - Nalepka, Jennifer L.

AU - Lee, Michael J.

AU - Kraay, Matthew J.

AU - Marcus, Randall E.

AU - Goldberg, Victor M.

AU - Chen, Xin

AU - Greenfield, Edward M.

PY - 2006/10

Y1 - 2006/10

N2 - Aseptic loosening of orthopaedic implants occurs in the absence of clinical signs of infection. Nevertheless, bacterial endotoxins derived from subclinical infections, systemic sources, or the implant manufacturing process may contribute to aseptic loosening. Also, the rate of implant infection is greater in patients with inflammatory arthritis than in patients with osteoarthritis. We hypothesized that lipopolysaccharide, the classic endotoxin derived from gram-negative bacteria, is more prevalent in periprosthetic tissue surrounding aseptically loose implants in patients with inflammatory arthritis than in patients with osteoarthritis. To test this, we used a modified Limulus amebocyte assay not affected by β-glucan-like molecules in mammalian tissues. Lipopolysaccharide rarely was detected in periprosthetic tissue from patients with osteoarthritis and aseptic loosening (one of six patients). In contrast, lipopolysaccharide was detected despite the absence of any clinical signs of infection in peri-prosthetic tissue from all four patients with inflammatory arthritis (rheumatoid arthritis, juvenile rheumatoid arthritis, and systemic lupus erythematosus). Lipopolysaccharide also was detected in two patients with gram-negative infections, who were included as positive control subjects. Endotoxins derived from low-grade or systemic bacteremia may be important contributors to aseptic loosening particularly in patients with autoimmune conditions such as inflammatory arthritis.

AB - Aseptic loosening of orthopaedic implants occurs in the absence of clinical signs of infection. Nevertheless, bacterial endotoxins derived from subclinical infections, systemic sources, or the implant manufacturing process may contribute to aseptic loosening. Also, the rate of implant infection is greater in patients with inflammatory arthritis than in patients with osteoarthritis. We hypothesized that lipopolysaccharide, the classic endotoxin derived from gram-negative bacteria, is more prevalent in periprosthetic tissue surrounding aseptically loose implants in patients with inflammatory arthritis than in patients with osteoarthritis. To test this, we used a modified Limulus amebocyte assay not affected by β-glucan-like molecules in mammalian tissues. Lipopolysaccharide rarely was detected in periprosthetic tissue from patients with osteoarthritis and aseptic loosening (one of six patients). In contrast, lipopolysaccharide was detected despite the absence of any clinical signs of infection in peri-prosthetic tissue from all four patients with inflammatory arthritis (rheumatoid arthritis, juvenile rheumatoid arthritis, and systemic lupus erythematosus). Lipopolysaccharide also was detected in two patients with gram-negative infections, who were included as positive control subjects. Endotoxins derived from low-grade or systemic bacteremia may be important contributors to aseptic loosening particularly in patients with autoimmune conditions such as inflammatory arthritis.

UR - http://www.scopus.com/inward/record.url?scp=33749443907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749443907&partnerID=8YFLogxK

U2 - 10.1097/01.blo.0000224050.94248.38

DO - 10.1097/01.blo.0000224050.94248.38

M3 - Article

C2 - 16735873

AN - SCOPUS:33749443907

SP - 229

EP - 235

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 451

ER -